Stocks and Investing
Stocks and Investing
Wed, March 2, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Nick Giovacchini Maintained (ACHC) at Buy with Increased Target to $78 on, Mar 2nd, 2022
Nick Giovacchini of Credit Suisse, Maintained "Acadia Healthcare Company, Inc." (ACHC) at Buy with Increased Target from $74 to $78 on, Mar 2nd, 2022.
Nick has made no other calls on ACHC in the last 4 months.
There is 1 other peer that has a rating on ACHC. Out of the 1 peers that are also analyzing ACHC, 0 agree with Nick's Rating of Hold.
This is the rating of the analyst that currently disagrees with Nick
- Whit Mayo of "SVB Leerink" Maintained at Buy with Decreased Target to $80 on, Tuesday, March 1st, 2022
Contributing Sources